Clinical trials: Behcet Syndrome

Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP)

Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)

• Enrolling by invitation
• Age: 18 to 85 years
• Phase 1

This is a long-term extension trial of RAY121 in patients with immunological diseases such as antiphospholipid syndrome (APS), bullous pemphigoid (BP), Behçet's Syndrome (BS), dermatomyositis (DM), immune-mediated necrotizing…

Conditions

Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM)

Trial name

NCT06723106

Testing

RAY121

Where

62 sites in Australia, Austria and 17 more

Volunteers

144 people

Sponsor

Chugai Pharmaceutical